Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET)

Vinik, Aaron; Van Cutsem, Eric; Niccoli, Patricia; Raoul, Jean-Luc; Bang, Yung-Jue; Borbath, Ivan; Lombard-Bohas, Catherine; Valle, Juan W; Metrakos, Peter; Smith, Denis; Chen, Jen-Shi; Hoersch, Dieter; Castellano, Daniel E; Kennecke, Hagen F; Picus, Joel; Van Hazel, Guy; Patyna, Shem; Lu, Dongrui Ray; Chao, Richard C; Raymond, Eric

Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET)

Author:

Vinik, Aaron

Van Cutsem, Eric ; Niccoli, Patricia ; Raoul, Jean-Luc ; Bang, Yung-Jue ; Borbath, Ivan ; Lombard-Bohas, Catherine ; Valle, Juan W ; Metrakos, Peter ; Smith, Denis ; Chen, Jen-Shi ; Hoersch, Dieter ; Castellano, Daniel E ; Kennecke, Hagen F ; Picus, Joel ; Van Hazel, Guy ; Patyna, Shem ; Lu, Dongrui Ray ; Chao, Richard C ; Raymond, Eric

Keywords:

Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology, 1103 Clinical Sciences, 3202 Clinical sciences